Dividends CalendarEarnings Calendar
ICPT

ICPT | Intercept Pharma

29.19 -0.61 (-2.13%) 
Intercept Pharma
Category: Company
  • Industry: Drug Manufacturers - Major

Quick infos

  • Headquarters:   United States of America

Trade prices

  • Volume:
  • Market Cap: 928.41M
  • Prev closed: 39.65
  • Open: 39.9
  • High: 40.41
  • Low: 38.96
  • 52 week low: 38.96
  • 52 week high: 125
  • Dividends:No Dividends

Next ER: November 9, 2020  Before Market Opens



Top Stories (ICPT)

    About the Company

    Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    February 23, 2021
    November 9, 2020-2.01 / -1.9979.52M / 78.67MBeat!
    August 10, 2020-1.92 / -2.8877.25M / 72.45MBeat!
    July 30, 2020- / -2.94- / 72.01M
    May 11, 2020-2.86 / -2.9472.65M / 69.67MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jan 12, 2021 28.66 31.36
    31.66
    28.66
    982.36K -8.32%
    Jan 11, 2021 31.26 31.10
    31.38
    30.41
    702.78K 0.55%
    Jan 8, 2021 31.09 31.72
    31.73
    30.19
    1.07M -0.22%
    Jan 7, 2021 31.16 30.50
    31.59
    30.14
    985.40K 3.62%
    Jan 6, 2021 30.07 31.10
    31.11
    29.25
    1.53M -3.47%
    Jan 5, 2021 31.15 27.65
    31.25
    27.30
    2.30M 13.73%
    Jan 4, 2021 27.39 24.21
    27.77
    24.01
    1.61M 10.89%
    Dec 31, 2020 24.70 25.46
    26.83
    24.48
    1.83M -3.48%
    Dec 30, 2020 25.59 24.48
    25.99
    24.25
    1.40M 4.53%
    Dec 29, 2020 24.48 25.50
    26.00
    24.47
    1.17M -4.49%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2002
    • Employees:456

    News

    News for (ICPT)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Mark E. Pruzanski, MD
    • Chief Human Resources Officer :  David Ford

    Talk about Intercept Pharma below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 9, 2020 (Same day)

    icpt zyne iii unit cara tlry bynd nvax brfs bhvn 


    Jump to (Finance sites)

    Their Official Profiles 

    WikipediaTwitterLinkedIn

    Peers / Similar stocks 

    xlv gild lly bmy 

    Other stocks 

    mcd snap fb jnj t bac ual low vfc xlnx dwdp five 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Investing For Dummies
    Buy on Amazon

    In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals.